# Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries

> **NCT02581644** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 63 (actual)

## Conditions studied

- Renal Transplant

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02581644
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-29
- **Primary completion:** 2017-05-19
- **Final completion:** 2017-05-19
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02581644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02581644, "Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02581644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*